SQSTM1/p62: A Potential Target for Neurodegenerative Disease | ACS Chemical Neuroscience
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment: Trends in Pharmacological Sciences
Biomarkers for neurodegenerative diseases | Nature Medicine
Empowering Physicians to Advance the Future of Alzheimer's Disease - EMJ
Blood Tests for Alzheimer Disease - Practical Neurology
Biomarkers in vascular dementia: A recent update - ScienceDirect
A Primary Care Agenda for Brain Health: A Scientific Statement From the American Heart Association | Stroke
The biomarker-based diagnosis of Alzheimer's disease. 2—lessons from oncology - ScienceDirect
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. - Abstract - Europe PMC
Full article: The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases
Biomarker Development: A Tool to Prevent Neurodegenerative Disorders | UC Davis Biotechnology Program
Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021 | SpringerLink
Preclinical markers of neurodegenerative diseases | Download Table
Recognizing Subtle Signs of Early Stage Neurodegeneration - Holistic Primary Care
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease - Hansson - 2022 - Alzheimer's & Dementia - Wiley Online Library
Brain pathological changes during neurodegenerative diseases and their identification methods: How does QSM perform in detecting this process? | Insights into Imaging | Full Text
Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay | Molecular Neurodegeneration | Full Text
Medicina | Free Full-Text | Biomarkers for Alzheimer’s Disease: Context of Use, Qualification, and Roadmap for Clinical Implementation
Recent Research into Neurodegenerative Diseases
Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study - The Lancet
Cerebrospinal fluid biomarkers to monitor treatment effects in Alzheimer's disease and related conditions
Biomarkers for neurodegenerative diseases | Nature Medicine
Medicina | Free Full-Text | Biomarkers for Alzheimer’s Disease: Context of Use, Qualification, and Roadmap for Clinical Implementation
Neuroimmune Connections in Aging and Neurodegenerative Diseases: Trends in Immunology
Understanding neurodegeneration after traumatic brain injury: from mechanisms to clinical trials in dementia | Journal of Neurology, Neurosurgery & Psychiatry
